Enter your terms above and click the 'Search' button.

Showing articles 0 to 8 of 8 Filter Applied: amyloid beta protein (Click to remove) CSF and Plasma Biomarkers in Patients with Iatrogenic Cerebral Amyloid Angiopathy Neurol 103:e209828, Pollaci,G.,et al, 2024 Lecanemab in Early Alzheimers Disease NEJM 388:9-21,80, van Dyck,A.H.,et al, 2023 Donanemab in Early Symptomatic Alzheimer Disease, The TRAILBLAZER-ALZ 2 Randomized Clinical Trial JAMA 330:512-517, 510, Sims,J.R.,et al, 2023 Blook Transfusion and Brain Amyloidosis, Should We Be Worried? JAMA 330:921-922, Greenberg,S.M., 2023 Controversy and Progress in Alzheimers Disease - FDA Approval of Aducanumab NEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021 Sporadic Cerebral Amyloid Angiopathy Revisited: Recent Insights Into Pathophysiology and Clinical Spectrum JNNP 83:124-137, Charidimou,A.,et al, 2012 DNA �-Amyloid1-42 Trimer Immunization for Alzheimer Disease in a Wild-Type Mouse Model JAMA 302:1796-1802, Lambracht-Washington,D.,et al, 2009 Phase 2 Safety Trial Targeting Amyloid � Production With a ?-Secretase Inhibitor in Alzheimer Disease Arch Neurol 65:1031-1038, Fleisher,A.S.,et al., 2008 Showing articles 0 to 8 of 8